Loading cancer entity…
Loading cancer entity…
Clinical trials
17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02249052 | Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma | completed | Phase 2 | 19 | Gerut, Zachary, M.D.INDIV | 1 | Feb 23, 2017 | clinicaltrials |
| NCT01613313 | A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma | completed | Phase 2 | 14 | Zachary GerutINDIV | 1 | Oct 6, 2016 | clinicaltrials |
| NCT00608842 | Phase 2 Study for the Treatment of Superficial Lipomas | completed | Phase 2 | 62 | Kythera BiopharmaceuticalsINDUSTRY | 1 | Jan 14, 2016 | clinicaltrials |
| NCT00624416 | Association of Beta-2 Adrenergic Agonist and Corticosteroid Injection in the Treatment of Lipomas |
Data updated 22 days agoSource updated Feb 23, 2017source: clinicaltrials
| completed |
| Phase 1 / Phase 2 |
| 10 |
| Pennington Biomedical Research CenterOTHER |
| 1 |
| Dec 21, 2015 |
| clinicaltrials |
| NCT00792766 | Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM) | completed | Phase 1 / Phase 2 | 20 | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Sep 18, 2013 | clinicaltrials |